[Inhibition of lactation by bromocriptine. 470 cases over a 3-year period].
Three years of experimental work on 470 cases have given us the opportunity of confirming the usefulness of 2-Bromo-ergocryptine and the excellent way it is tolerated when used for inhibition of lactation. The dosage which is necessary to achieve an approximately 100 p. 100 success rate has been worked out in detail. Pharmacological study has shown that the substance is effective because it inhibits the secretion of prolactin by the pituitary gland.
D001971:Bromocriptine / Q000009:adverse effects / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007774:Lactation / Q000187:drug effects*; D011247:Pregnancy
D001971:Bromocriptine
Inhibition de la lactation par la bromocriptine. 470 observations recueillies en 3 ans.